Clinical Trials
At Quimatryx, we are working on groundbreaking therapies through clinical trials.
Our selective HDAC6 inhibitor QTX125 is currently being tested to address cancer, aiming to offer new treatment options for conditions with high unmet need. Let us know if you are:
At Quimatryx, we are committed to the advancement of precision medicine through clinical trials that explore the therapeutic potential of our innovative epigenetic therapies. As we progress in the development of our selective HDAC6 inhibitors, our clinical trials are designed to provide critical insights into the safety and efficacy of our treatments across a range of diseases, including cancer, neuronal conditions, and autoimmune disorders.
We aim to transform the treatment landscape by testing novel drugs in clinical settings, bringing us one step closer to delivering groundbreaking therapies to patients with high unmet medical needs. Our trials are meticulously designed to ensure that each phase meets the highest standards of safety, ethics, and scientific rigor.
What is a Clinical Trial?
A clinical trial is a key element for developing new treatments.
It allows researchers to evaluate the safety, effectiveness, and potential benefits of newly developed therapies in human participants. By thoroughly testing treatments in clinical trials, we can determine whether a new drug offers therapeutic benefits and if it’s safe for widespread use.
At Quimatryx, we conduct clinical trials in compliance with national and international regulations, ensuring that patient rights are fully protected. Each trial is conducted ethically, with participants carefully selected based on specific criteria relevant to the condition treated.
How is a Clinical Trial conducted?
Before a new treatment is tested in patients, it undergoes extensive laboratory and animal testing during the preclinical phase. This helps determine the safety and potential effectiveness of the drug. Once promising results are obtained, the drug is selected for clinical trials to assess its impact on human health.
Clinical trials are typically conducted in several phases, each serving a specific purpose:
Phase I
This phase focuses on evaluating the safety of the drug in humans. Researchers assess how the body processes the drug, determine the most effective way to administer it, and identify the optimal dosage. Phase I typically involves a small group of healthy volunteers or patients.
Phase II
In this phase, the drug is tested for its effectiveness and continued safety in a larger group of patients who have the condition the drug is intended to treat. The goal is to gather more comprehensive data on the treatment’s potential benefits.
Phase III
This phase confirms the therapeutic benefits and safety of the treatment in a much larger patient group. It helps determine whether the new therapy offers a clear advantage over existing treatments.
Phase IV
Once a drug has been approved and released to the market, phase IV trials gather additional information about the drug’s long-term effects, safety, and efficacy in a larger population.
More information on clinical trials:
Patients
Clinical trials offer an opportunity to access new treatments that may not yet be available on the market. Participation in a clinical trial can provide patients with access to novel therapies that have the potential to improve their condition.
To participate in our trials, patients must meet specific criteria, ensuring that the results are applicable and relevant. If you are interested in learning more about the clinical trials for QTX125, or if you would like to explore potential eligibility, please get in touch.
Researchers
We are always looking to collaborate with medical professionals and researchers to further the development of our therapies. If you are an investigator interested in learning more about our trials, we would be happy to discuss the progress and potential of our clinical programs.
For more information or to explore our trials, please contact us directly.
